These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24871332)

  • 21. Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study.
    Fischer MA; Gnannt R; Raptis D; Reiner CS; Clavien PA; Schmidt B; Leschka S; Alkadhi H; Goetti R
    Invest Radiol; 2011 Jun; 46(6):351-8. PubMed ID: 21263329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dual-source dual-energy computed tomography imaging of acute necrotizing pancreatitis--Preliminary study].
    Yuan Y; Huang ZX; Li ZL; Bin S; Deng LP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):691-4. PubMed ID: 22007500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced computed tomography lymphangiography with intranodal injection of water-soluble iodine contrast media in microminipig: imaging protocol and feasibility.
    Tanahashi Y; Iwasaki R; Shoda S; Kawada H; Ando T; Takasu M; Hyodo F; Goshima S; Mori T; Matsuo M
    Eur Radiol; 2020 Nov; 30(11):5913-5922. PubMed ID: 32591882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on the optical scan condition for imaging of multi-slice spiral CT liver perfusion in rats.
    Bai RJ; Wang JE; Jiang HJ; Hao XJ; Dong XP; Huang YH; Wei L
    Chin Med J (Engl); 2013; 126(24):4742-6. PubMed ID: 24342322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocol analysis of dual-energy CT for optimization of kidney stone detection in virtual non-contrast reconstructions.
    Lazar M; Ringl H; Baltzer P; Toth D; Seitz C; Krauss B; Unger E; Polanec S; Tamandl D; Herold CJ; Toepker M
    Eur Radiol; 2020 Aug; 30(8):4295-4305. PubMed ID: 32242275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced computed tomography for the quantification of tumor response to vasoactive agents in a rat tumor model: preliminary results.
    Pollard RE; Larson RF
    Contrast Media Mol Imaging; 2011; 6(1):28-34. PubMed ID: 20690160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of iodine uptake and perfusion parameters between dual-energy CT imaging and first-pass dual-input perfusion CT in lung cancer.
    Chen X; Xu Y; Duan J; Li C; Sun H; Wang W
    Medicine (Baltimore); 2017 Jul; 96(28):e7479. PubMed ID: 28700488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response.
    Eisa F; Brauweiler R; Hupfer M; Nowak T; Lotz L; Hoffmann I; Wachter D; Dittrich R; Beckmann MW; Jost G; Pietsch H; Kalender WA
    Eur Radiol; 2012 Apr; 22(4):900-7. PubMed ID: 22071777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximizing Iodine Contrast-to-Noise Ratios in Abdominal CT Imaging through Use of Energy Domain Noise Reduction and Virtual Monoenergetic Dual-Energy CT.
    Leng S; Yu L; Fletcher JG; McCollough CH
    Radiology; 2015 Aug; 276(2):562-70. PubMed ID: 25860839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-energy CT iodine maps as an alternative quantitative imaging biomarker to abdominal CT perfusion: determination of appropriate trigger delays for acquisition using bolus tracking.
    Skornitzke S; Fritz F; Mayer P; Koell M; Hansen J; Pahn G; Hackert T; Kauczor HU; Stiller W
    Br J Radiol; 2018 May; 91(1085):20170351. PubMed ID: 29446319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US.
    Sugimoto K; Moriyasu F; Saito K; Rognin N; Kamiyama N; Furuichi Y; Imai Y
    Liver Int; 2013 Apr; 33(4):605-15. PubMed ID: 23305331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep learning-based virtual noncontrast CT for volumetric modulated arc therapy planning: Comparison with a dual-energy CT-based approach.
    Koike Y; Ohira S; Akino Y; Sagawa T; Yagi M; Ueda Y; Miyazaki M; Sumida I; Teshima T; Ogawa K
    Med Phys; 2020 Feb; 47(2):371-379. PubMed ID: 31733105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early evaluation of targeted therapy effectiveness in non-small cell lung cancer by dynamic contrast-enhanced CT.
    Qiao PG; Zhang HT; Zhou J; Li M; Ma JL; Tian N; Xing XD; Li GJ
    Clin Transl Oncol; 2016 Jan; 18(1):47-57. PubMed ID: 26243393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can quantitative iodine parameters on DECT replace perfusion CT parameters in colorectal cancers?
    Kang HJ; Kim SH; Bae JS; Jeon SK; Han JK
    Eur Radiol; 2018 Nov; 28(11):4775-4782. PubMed ID: 29789907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Explanations for the heterogeneity of splenic enhancement derived from blood flow kinetic measurements using dynamic contrast-enhanced CT (DCE-CT).
    Sauter AW; Spira D; Schulze M; Horger MS
    Acta Radiol; 2014 Jul; 55(6):645-53. PubMed ID: 24005563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of spectral separation: an assessment of dual-energy spectral separation for quantitative ability and dose efficiency.
    Krauss B; Grant KL; Schmidt BT; Flohr TG
    Invest Radiol; 2015 Feb; 50(2):114-8. PubMed ID: 25373305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
    Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
    Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results.
    Frampas E; Lassau N; Zappa M; Vullierme MP; Koscielny S; Vilgrain V
    Eur J Radiol; 2013 May; 82(5):e205-11. PubMed ID: 23273822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic renal cell carcinoma: preliminary results from the Danish Renal Cancer Group Study-1.
    Mains JR; Donskov F; Pedersen EM; Madsen HH; Rasmussen F
    Invest Radiol; 2014 Sep; 49(9):601-7. PubMed ID: 24691140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodine concentration and tissue attenuation in dual-energy contrast-enhanced CT as a potential quantitative parameter in early detection of local pancreatic carcinoma recurrence after surgical resection.
    Mathy RM; Fritz F; Mayer P; Klauss M; Grenacher L; Stiller W; Kauczor HU; Skornitzke S
    Eur J Radiol; 2021 Oct; 143():109944. PubMed ID: 34482176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.